【英语财经】辉瑞承认收购阿斯利康后将裁员 Pfizer admits jobs and R&D budget will fall if AstraZeneca move succeeds

  • 【英语财经】辉瑞承认收购阿斯利康后将裁员 Pfizer admits jobs and R&D budget will fall if AstraZeneca move succeeds已关闭评论
  • 30 views
  • A+
所属分类:双语财经

2014-5-14 06:30

小艾摘要: Pfizer will cut its research budget and global headcount if it succeeds in taking over AstraZeneca, the US drugs maker acknowledged yesterday, amid mounting expectations that it will raise the informa ...
Pfizer admits jobs and R&D budget will fall if AstraZeneca move succeeds
Pfizer will cut its research budget and global headcount if it succeeds in taking over AstraZeneca, the US drugs maker acknowledged yesterday, amid mounting expectations that it will raise the informal £63bn offer for its UK rival.

Ian Read, Pfizer chief executive and chairman, refused to rule out job cuts in the UK as he was pressed by British lawmakers about his plans for the country’s second-biggest pharmaceuticals company.

Mr Read had been summoned to London for two days of parliamentary hearings, as public debate over the implications of the proposed deal for the UK’s life sciences sector intensified.

The tone for the 81-minute grilling was set when Adrian Bailey, chairman of the business committee, noted that Pfizer had been called a “praying mantis” and “a shark that needs feeding”.

UK politicians, led by David Cameron, the prime minister, say firmer guarantees on jobs and investment are needed to win their blessing for any deal. Vince Cable, the business secretary, is investigating what legal options the UK would have to frustrate the bid should their demands not be met.

Mr Read reiterated his commitment to keep 20 per cent of the combined research workforce in Britain for at least five years but refused to go further on specific job commitments.

The chief executive told MPs that his company’s pledge to commit a fifth of its R&D spending to the UK was an “unprecedented” and “substantial” commitment.

But he admitted that an enlarged company would whittle back its employee numbers and overall R&D budget should the deal go ahead.

美国制药公司辉瑞(Pfizer)昨日承认,如果成功收购其英国竞争对手阿斯利康(AstraZeneca),就会削减研发预算并在全球裁员。目前各方日益预期辉瑞将提高其630亿英镑收购阿斯利康的非正式报价。

辉瑞董事长兼首席执行官伊恩?里德(Ian Read)在就其并购英国第二大制药公司的计划接受英国议员质询时,拒绝排除在英国裁员的可能性。

在英国公众围绕这项拟议交易对英国生命科学领域的影响展开激烈辩论之际,里德被传唤至伦敦参加英国议会为期两天的听证会。

当英国议会商业委员会主席阿德里安?贝利(Adrian Bailey)指出辉瑞曾被称为“螳螂”和“需要进食的鲨鱼”的时候,这场持续81分钟的质询的基调已经确立。

以首相戴维?卡梅伦(David Cameron)为首的英国政客们表示,只有辉瑞在就业和投资方面做出更为有力的保证,他们才会支持这笔交易。英国商业大臣文斯?凯布尔(Vince Cable)正在研究,如果辉瑞未能满足他们的要求,英国政府可以选择哪些法律手段来阻碍交易。

里德重申了在交易完成后至少5年内将两家公司20%的研发人员留在英国的承诺,但拒绝进一步作出具体的就业承诺。

他告诉英国的议员们,辉瑞将20%的研发支出投向英国的承诺是“史无前例”和“重大”的。

但他承认,如果完成交易,合并后的公司将会裁员并削减整体研发预算。

译者/邹策

本文关键字:财经英语,小艾英语,双语网站,财经双语,财经资讯,互联网新闻,ERWAS,行业解析,创业指导,营销策略,英语学习,可以双语阅读的网站!
  • 我的微信
  • 这是我的微信扫一扫
  • weinxin
  • 我的微信公众号
  • 我的微信公众号扫一扫
  • weinxin